US loss of exclusivity · Cardiometabolic
Vyndaqel
Pfizer
2031
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$6.4B
Date basis
Settlement / court date
US generics
Filed with the FDA
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Vyndaqel timeline →